Literature DB >> 17699251

Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality.

L Ebony Boulware1, Yongmei Liu, Nancy E Fink, Josef Coresh, Daniel E Ford, Michael J Klag, Neil R Powe.   

Abstract

Temporal relationships among depression, medical comorbidity, and death or cardiovascular disease (CVD) events are complex. Clarifying temporal relationships may enhance current insight regarding the nature of the association of depression with poor outcomes. The temporal relation of depression symptoms (DS; score < or = 52 on five-item Mental Health Index) assessed at 6-mo intervals for 2 yr to CVD event, all-cause death, cardiovascular disease deaths, and non-cardiovascular disease deaths was studied in 917 incident dialysis patients. Cox regression models were used to assess whether the proximity of DS measurement and DS duration would change observed associations between DS and events. Whether increasing medical comorbidity was associated with worsening DS also was assessed. In time-varying models, DS were strongly associated with all-cause deaths, cardiovascular disease deaths, and CVD events (adjusted relative hazard [95% confidence interval]: 2.22 [1.36 to 3.60], 3.27 [1.57 to 6.81], and 1.68 [1.05 to 2.69], respectively). Persistent and current DS were associated with greater risks for all-cause death. Incorporating a 6-mo time lag between DS and outcomes attenuated risks for all-cause death, non-cardiovascular disease deaths, and CVD events. In a subgroup analysis, patients with worsening medical comorbidity (n = 32) during the first year of follow-up experienced a 2.42-point greater decline in mental health scores at 2 yr of follow-up compared with patients with no worsening in medical comorbidity (n = 123), but findings were not statistically significant. DS are strongly related to death and CVD events, with persistent/current DS most strongly associated with poor outcomes. Attenuated risks from time-lag analyses indicate a partial role for reverse causality, suggesting that medical comorbidity may precede DS.

Entities:  

Mesh:

Year:  2006        PMID: 17699251     DOI: 10.2215/CJN.00030505

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  60 in total

1.  Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease.

Authors:  Michael J Fischer; Paul L Kimmel; Tom Greene; Jennifer J Gassman; Xuelei Wang; Deborah H Brooks; Jeanne Charleston; Donna Dowie; Denyse Thornley-Brown; Lisa A Cooper; Marino A Bruce; John W Kusek; Keith C Norris; James P Lash
Journal:  Kidney Int       Date:  2011-06-01       Impact factor: 10.612

2.  Depression and cognitive function in maintenance hemodialysis patients.

Authors:  Brian T Agganis; Daniel E Weiner; Lena M Giang; Tammy Scott; Hocine Tighiouart; John L Griffith; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2010-07-29       Impact factor: 8.860

3.  Prevalence of Depressive Symptoms among Hemodialysis and Peritoneal Dialysis Patients.

Authors:  AbdulRhman AlDukhayel
Journal:  Int J Health Sci (Qassim)       Date:  2015-01

Review 4.  A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease.

Authors:  S Susan Hedayati; Venkata Yalamanchili; Fredric O Finkelstein
Journal:  Kidney Int       Date:  2011-10-19       Impact factor: 10.612

5.  Thyroid Status, Quality of Life, and Mental Health in Patients on Hemodialysis.

Authors:  Connie M Rhee; Yanjun Chen; Amy S You; Steven M Brunelli; Csaba P Kovesdy; Matthew J Budoff; Gregory A Brent; Kamyar Kalantar-Zadeh; Danh V Nguyen
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-13       Impact factor: 8.237

Review 6.  Assessing and improving the health-related quality of life of patients with ESRD.

Authors:  Fredric O Finkelstein; Kelli L Arsenault; Ana Taveras; Kwabena Awuah; Susan H Finkelstein
Journal:  Nat Rev Nephrol       Date:  2012-10-23       Impact factor: 28.314

7.  Treatment of depression and poor mental health among patients receiving maintenance dialysis: are there options other than a pill or a couch?

Authors:  Michael J Fischer; Anna C Porter; James P Lash
Journal:  Am J Kidney Dis       Date:  2013-05       Impact factor: 8.860

8.  Sertraline treatment is associated with an improvement in depression and health-related quality of life in chronic peritoneal dialysis patients.

Authors:  Huseyin Atalay; Yalcin Solak; Murat Biyik; Zeynep Biyik; Mehdi Yeksan; Faruk Uguz; Ibrahim Guney; Halil Zeki Tonbul; Suleyman Turk
Journal:  Int Urol Nephrol       Date:  2009-12-02       Impact factor: 2.370

9.  Depression and all-cause mortality in hemodialysis patients.

Authors:  Li Fan; Mark J Sarnak; Hocine Tighiouart; David A Drew; Amy L Kantor; Kristina V Lou; Kamran Shaffi; Tammy M Scott; Daniel E Weiner
Journal:  Am J Nephrol       Date:  2014-06-24       Impact factor: 3.754

10.  Prevalence of major depressive episode in CKD.

Authors:  S Susan Hedayati; Abu T Minhajuddin; Robert D Toto; David W Morris; A John Rush
Journal:  Am J Kidney Dis       Date:  2009-06-03       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.